[Can the persistence rate of transurethrally resected bladder tumors be lowered by postoperative instillation of silver nitrate?].
In 19 out of 88 patients (22%) who had undergone transurethral resection of urothelial carcinoma of the urinary bladder persistent tumours occurred (= tumour detected locally within 3 months). Among 52 patients who had had TUR of urothelial carcinoma and postoperative silver nitrate instillation persistent tumours were found in 11 cases (21%). The persistence rate correlates to the depth of infiltration and the dedifferentiation of the primary tumour. Even in homogenous follow-up groups immediate postoperative instillation of silver nitrate shows no effect on the persistence rate.
D002295:Carcinoma, Transitional Cell / Q000473:pathology / Q000601:surgery*; D003131:Combined Modality Therapy; D006801:Humans; D009364:Neoplasm Recurrence, Local / Q000473:pathology; D011182:Postoperative Care; D012835:Silver Nitrate / Q000008:administration & dosage*; D007507:Therapeutic Irrigation; D001743:Urinary Bladder / Q000473:pathology; D001749:Urinary Bladder Neoplasms / Q000473:pathology / Q000601:surgery*
D012835:Silver Nitrate
Kann die Persisterrate von transurethral resezierten Harnblasentumoren durch postoperative Instillation von Silbernitrat gesenkt werden?